TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity
PopART trial shows feasibility of reaching 90-90-90 targets for testing and treatment coverage in Zambia and South Africa
Botswana close to reaching the 90-90-90 testing and treatment targets
Cotrimoxazole prophylaxis provides no benefit for HIV-exposed uninfected children
Partner notification feasible and effective in African settings
Very high levels of chemsex and ‘slamsex’ seen in HIV-positive men attending English/Welsh HIV clinics
Option B+ cuts mother-to-child HIV transmission dramatically in Malawi
Starting HIV treatment at first clinic visit improves outcomes in African study
Major disparities persist in lifetime risk of HIV diagnosis in the US
